Pillcheck PGx launches new program for benefits advisors on the heels of positive study results in the mental health area

The new program builds on the successful introduction of Pillcheck pharmacogenetics by many insurers seeking to impact the frequency and duration of Short-Term and Long-Term disability claims. Now the same rigorously evaluated, secure service is available to plans and benefit advisors on a subscription basis or as a private...

New Pillcheck Study in Long Term Care shows the potential benefit of matching people’s drug treatment to their DNA in Elder Care

Study shows that over 80% could benefit from a pharmacogenetic test and improve treatment. Many older adults, especially those in elder care, are at risk of harmful medication-related side effects. Often, the issues are preventable with an easy pharmacogenetic test and a medication review by an expert pharmacist. A recent study involving...

Do Genetic Tests Belong in Benefit Plans?

Genetic tests can provide predictive insights into many domains, such as ancestry, inherited predisposition to disease or your body’s ability to respond to a certain medication treatment – pharmacogenetics. Veronika Litinski, Pillcheck’s CEO, discusses the benefits for plans and the context for successfully implementing precision medicine with plan members. See...

Pharmacogenetic Testing May Improve Drug Treatments and Shorten Disability

This article in Benefits Quarterly for first quarter 2017 describes how methods of personalized medicine — specifically, pharmacogenetic (PGx) testing— can benefit private health plans, benefits managers, care providers and consumers alike. The authors cover pharmacogenomics as a science and also introduce an innovative way to optimize drug treatments....

Skip to content